Ananym Capital Management LP Takes $32.63 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Ananym Capital Management LP purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 471,507 shares of the company's stock, valued at approximately $32,628,000. Henry Schein accounts for about 19.8% of Ananym Capital Management LP's portfolio, making the stock its biggest holding. Ananym Capital Management LP owned about 0.38% of Henry Schein at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Palestra Capital Management LLC acquired a new stake in Henry Schein during the fourth quarter worth about $182,988,000. Lyrical Asset Management LP purchased a new position in shares of Henry Schein during the 4th quarter valued at approximately $126,655,000. Norges Bank acquired a new stake in Henry Schein during the fourth quarter valued at $103,301,000. National Bank of Canada FI increased its stake in shares of Henry Schein by 102.4% in the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company's stock valued at $75,048,000 after purchasing an additional 548,561 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Henry Schein in the fourth quarter valued at approximately $34,720,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Stock Up 1.3 %

Shares of NASDAQ:HSIC opened at $65.30 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The stock has a market cap of $8.00 billion, a price-to-earnings ratio of 26.87, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The firm's 50 day moving average price is $68.01 and its 200 day moving average price is $71.59.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and increased their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Piper Sandler decreased their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and a consensus target price of $80.20.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.